EGFR and metastatic colorectal cancer: The recommended treatment for individuals with metastatic colorectal cancer (mCRC) involves chemotherapy protocols that include fluorouracil, oxaliplatin, and/or irinotecan, together with medications that target angiogenesis (bevacizumab) or the epidermal growth factor receptor (cetuximab) (46, 47).